NORTHEAST FINANCIAL CONSULTANTS INC – Regeneron Pharmaceuticals, Inc. Transaction History
NORTHEAST FINANCIAL CONSULTANTS INC portfolio value:
$1.27M
portfolio value
NORTHEAST FINANCIAL CONSULTANTS INC quarter portfolio value change:
+16.53%
quarter
Regeneron Pharmaceuticals, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | 0.00% | 0 shares | 181K | $688.87 | 1.84K | |
| Q2 2022 | share | Decrease | -5.15% | -100 shares | -268K | $591.13 | 1.84K |
| Q1 2022 | share | Increase | +5.43% | 100 shares | 193K | $698.42 | 1.94K |
| Q4 2021 | share | 0.00% | 0 shares | 49K | $642.51 | 1.84K | |
| Q3 2021 | share | Decrease | -2.12% | -40 shares | 64K | $605.18 | 1.84K |
| Q2 2021 | share | 0.00% | 0 shares | 160K | $558.54 | 1.88K | |
| Q1 2021 | share | Increase | +40.21% | 540 shares | 242K | $473.14 | 1.88K |
| Q4 2020 | share | Decrease | -2.89% | -40 shares | -125K | $483.11 | 1.34K |
| Q3 2020 | share | Decrease | -8.83% | -134 shares | -171K | $559.78 | 1.38K |
| Q2 2020 | share | Increase | +1.34% | 20 shares | 214K | $623.65 | 1.51K |
| Q1 2020 | share | Increase | +26.12% | 310 shares | 285K | $488.29 | 1.49K |
| Q4 2019 | share | Decrease | -1.25% | -15 shares | 113K | $375.48 | 1.18K |
| Q3 2019 | share | Decrease | -1.23% | -15 shares | -48K | $277.4 | 1.20K |
| Q2 2019 | share | Increase | +4.28% | 50 shares | -98K | $313 | 1.21K |
| Q1 2019 | share | Increase | 0.00% | 1.16K shares | 479K | $410.62 | 1.16K |